Omnia Family Wealth LLC Sells 662 Shares of Colgate-Palmolive (NYSE:CL)

Omnia Family Wealth LLC decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 10.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,576 shares of the company’s stock after selling 662 shares during the period. Omnia Family Wealth LLC’s holdings in Colgate-Palmolive were worth $444,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. OFI Invest Asset Management purchased a new stake in shares of Colgate-Palmolive during the third quarter valued at $25,000. Avion Wealth lifted its stake in Colgate-Palmolive by 78.1% in the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after acquiring an additional 175 shares during the period. McGlone Suttner Wealth Management Inc. purchased a new stake in Colgate-Palmolive in the fourth quarter worth about $34,000. Kayne Anderson Rudnick Investment Management LLC lifted its stake in Colgate-Palmolive by 142.0% in the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after acquiring an additional 291 shares during the period. Finally, West Branch Capital LLC lifted its position in shares of Colgate-Palmolive by 24.0% during the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after buying an additional 132 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 1.9 %

Shares of CL traded up $1.72 during midday trading on Friday, hitting $91.01. The company had a trading volume of 7,541,541 shares, compared to its average volume of 3,968,951. The company’s 50-day simple moving average is $87.66 and its 200-day simple moving average is $81.54. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The firm has a market capitalization of $74.81 billion, a P/E ratio of 28.80, a P/E/G ratio of 3.42 and a beta of 0.42. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $92.25.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.04. The business had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.73 EPS. As a group, sell-side analysts expect that Colgate-Palmolive will post 3.5 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.20%. The ex-dividend date is Friday, April 19th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Insider Activity

In related news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares in the company, valued at $22,797,983.85. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, Director C Martin Harris sold 2,760 shares of the business’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the sale, the director now owns 19,272 shares in the company, valued at $1,628,484. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the sale, the chief executive officer now owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. In the last quarter, insiders sold 232,371 shares of company stock worth $19,505,099. 0.34% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

CL has been the topic of several research reports. Evercore ISI increased their price target on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a report on Monday, April 8th. UBS Group increased their price target on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a report on Monday, January 29th. Morgan Stanley increased their price target on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a report on Monday, January 29th. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective on the stock in a research report on Monday, January 29th. Finally, StockNews.com lowered Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.